WQ97271 (e) Wedi’i gyflwyno ar 03/09/2025

Pa gynnydd sydd wedi'i wneud gan Lywodraeth Cymru tuag at gyflwyno Mounjaro fel cyffur colli pwysau ar draws byrddau iechyd?

Wedi'i ateb gan Ysgrifennydd y Cabinet dros Iechyd a Gofal Cymdeithasol | Wedi'i ateb ar 11/09/2025

Mounjaro® is available for prescription in Wales but should only be prescribed through specialist services as set out within the All-Wales Weight Management Pathway. The All Wales Weight Management Pathway (Adult weight management pathway 2021 | GOV.WALES) sets out our approach to the development of weight management services for patients in Wales, from early intervention to specialist support, and is consistent with National Institute for Health and Care Excellence (NICE) guidance. 

An addendum to the guidance sets out that weight management medication can be prescribed by a specialist service, where clinically indicated and in combination with a behavioural (lifestyle) intervention that includes a reduced-calorie diet and increased physical activity.

Further information about tirzepatide (Mounjaro) for weight management has been published and is available here: Tirzepatide (Mounjaro®) for the management of obesity and overweight (WHC/2025/018) [HTML] | GOV.WALES